Search Within

Molecular Pharmacology and Chemistry Program Faculty

Formats
  1. Journal Article (4981)
  2. Meeting Abstract (2012)
  3. Book Section (218)
  4. Conference Paper (122)
  5. Review (81)
  6. Editorial (50)
  7. Book Whole (30)
  8. Research Letter (15)
  9. Correspondence (8)
  10. Miscellaneous (6)
  11. Guidelines (2)
Groups
  1. Sloan Kettering Institute Faculty (7525)
  2. GSK Faculty (4733)
  3. Department of Medicine (2732)
  4. Surgery (2099)
  5. Center for Hematologic Malignancies (1836)
  6. Radiology, Department of (1826)

More Groups

People
  1. Murray Brennan (1060)
  2. Steven Larson (962)
  3. Peter Scardino (672)
  4. Michel Sadelain (586)
  5. Samuel Danishefsky (539)
  6. David Scheinberg (502)

More People

Years
  1. 2025 (67)
  2. 2024 (98)
  3. 2023 (122)
  4. 2022 (151)
  5. 2021 (155)
  6. 2020 (162)

More Years

Publications
  1. Blood (384)
  2. Journal of Nuclear Medicine (383)
  3. Cancer Research (340)
  4. Journal of Clinical Oncology (316)
  5. Annals of Surgical Oncology (181)
  6. International Journal of Radiation Oncology, Biology, Physics (176)

More Publications

Publishers
  1. American Association for Cancer Research (713)
  2. Elsevier Inc. (674)
  3. Nature Publishing Group (493)
  4. Springer (468)
  5. American Chemical Society (444)
  6. Elsevier Science, Inc. (406)

More Publishers

Results (7525)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Epichaperome inhibition targets kinase and TP53 mutant therapy resistant AML
    Meeting Abstract

    Carter, B. Z.; Mak, P. Y.; Tao, W.; Ostermann, L. B.; Nishida, Y.; Pemmaraju, N.; Boettcher, S.; Shpall, E. J.; Chiosis, G.; Karras, G.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Fructose treatment targets myeloid leukemogenesis in IDH2 mutants by exhausting alpha-ketoglutarate pools
    Meeting Abstract

    Savino, A. M.; Turner, B.; Jeong, S.; Schild, T.; Yang, X.; Luo, H.; Chirayil, R.; Cullen, Q.; Chan, M.; Han, G.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Patient-derived iPSCs faithfully represent the genetic diversity and cellular architecture of human acute myeloid leukemia
    Meeting Abstract

    Cruz-Rodriguez, N.; Kotini, A. G.; Carcamo, S.; Olszewska, M.; Bernard, E.; Luo, H.; Kharas, M. G.; Hasson, D.; Papapetrou, E. P.
    Blood (2022)

    Fulltext@MSK | Save
  • Combined genetic ablation of CD54 and CD58 in car engineered cytotoxic lymphocytes effectively averts allogeneic immune cell rejection
    Meeting Abstract

    Hammer, Q.; Perica, K.; Mbofung, R. M.; van Ooijen, H.; Varady, E.; Jelcic, M.; Pan, Y.; Momayyezi, P.; Groff, B.; Abujarour, R.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Impact of epichaperome inhibitor PU-H71 on anti-tumor T cell responses and its implications for immune and cellular therapy
    Meeting Abstract

    Martinet, J.; Sugita, M.; Alhomoud, M.; Abad, C.; Chiosis, G.; Roboz, G. J.; Boyer, O.; Guzman, M. L.
    Blood (2022)

    Fulltext@MSK | Save
  • RAF-Independent MEK mutations drive histiocytic neoplasms in vivo and are sensitive to single-agent ERK inhibition in patients
    Meeting Abstract

    Durham, B. H.; Singer, M. E.; Benbarche, S.; Erickson, C.; Rahman, J.; Solit, D. B.; Witkowski, M.; Rosen, N.; Abdel-Wahab, O.; Diamond, E. L.
    Blood (2022)

    Fulltext@MSK | Save
  • Target densities in malignant and normal cells determine CAR T cell efficacy and off-target hematotoxicity
    Meeting Abstract

    Haubner, S.; Mansilla-Soto, J.; Nataraj, S.; Kogel, F.; Chang, Q.; De Stanchina, E.; Fraser, K.; Park, J. H.; Wang, X.; Rivière, I.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Overcoming heterogeneity in AML with a novel or-gated HITCAR-1XX platform
    Meeting Abstract

    Haubner, S.; Mansilla-Soto, J.; Garcia Angus, A.; Chang, Q.; De Stanchina, E.; Sadelain, M.
    Blood (2022)

    Fulltext@MSK | Save
  • A phase I study of CD19-targeted 19(T2)28z1XX CAR T cells in adult patients with relapsed or refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Park, J. H.; Palomba, M. L.; Rivière, I.; Sikder, D. S.; Senechal, B.; Wang, X.; Bermudez, V. P.; Cathcart, E. R.; Liotta, K.; Joseph, J.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Dual IKZF2, and CK1α degrader targets acute myeloid leukemia cells
    Meeting Abstract

    Park, S. M.; Miyamoto, D.; Han, G.; Chan, M.; Curnutt, N.; Tran, N.; Velleca, A.; Kim, J. H.; Schurer, A.; Chang, K.; more...
    Blood (2022)

    Fulltext@MSK | Save